Abstracts Archive - Page 393 of 1683 - ATC Abstracts

2020 American Transplant Congress
The Role and Impact of Transplant Pharmacist Evaluation in a Pre-Kidney Transplant Clinic
B. Valdepenas, D. Choi, J. Benken, M. Campara
Pharmacy Practice and Transplant Surgery, University of Illinois at Chicago, Chicago, IL
*Purpose: The Centers for Medicare and Medicaid Services’ interpretative guidelines for conditions of participation for transplant centers define the transplant pharmacist’s role ambiguously. Limited evidence…
2020 American Transplant Congress
Inactive Status Change is an Independent Predictor of Waitlist Mortality and Disproportionately Impacts Patients in Donor Service Areas with a Higher Median MELD at Transplant
R. Batra¹, S. Noreen², D. Stewart³, D. Haakinson¹, G. Gan³, Y. Deng³, S. Kulkarni¹
¹Surgery, Yale University School of Medicine, New Haven, CT, ²UNOS, Richmond, VA, ³Yale University, New Haven, CT
*Purpose: Liver waitlist mortality is calculated by including both active and inactive patients. As inactive patients are unable to receive organ offers, models that adjust…
2020 American Transplant Congress
Immune-Mediated Injury and Eplet Mismatches – Profiling Population-Level Interactions
H. Mohammadhassanzadeh¹, W. Zhang², W. Klement³, H. Gebel⁴, P. Keown⁵, K. Oualkacha⁶, R. Sapir-Pichhadze¹
¹Medicine, McGill University, Montreal, QC, Canada, ²McGill University, Montreal, QC, Canada, ³Organ Donation and Transplantation, Canadian Blood Services, Ottawa, ON, Canada, ⁴Emory University Hospital, Atlanta, GA, ⁵Medicine, University of British Columbia, Vancouver, BC, Canada, ⁶Université du Québec À Montréal, Montreal, QC, Canada
*Purpose: HLA genes are in linkage disequilibrium with each other. Sequence defined HLA targets (eplets) are associated with alleles and may be shared within and…
2020 American Transplant Congress
Geographical Disparities in Transplantation: Exploring the Association between County Health Rankings and an Individual’s Access to Transplantation
A. J. Carter, R. D. Reed, D. Hendricks, K. N. Baldwin, A. C. Kale, J. E. Locke
Surgery, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Since 2004, living kidney donation has declined, with the southeastern United States disproportionately affected. Programs such as the Living Donor Navigator (LDN), designed to…
2020 American Transplant Congress
Relative Transplant Center Organ Volumes are Associated with Patient and Graft Survival
J. T. Adler, T. C. Tsai, S. K. Malek, S. G. Tullius, J. S. Weissman
Surgery, Brigham and Women's Hospital, Boston, MA
*Purpose: Transplant programs differ in relative volume of kidney and liver transplants. While there is a known volume-outcome relationship for organ-specific transplantation at an institutional…
2020 American Transplant Congress
Access to and Survival Benefit of Kidney Transplantation in Patients with Sickle Cell Disease-Associated End-Stage Renal Disease in the United States
S. Bae, M. Johnson, A. Massie, X. Luo, C. Haywood Jr., S. Lanzkron, M. Grams, D. Segev, T. Purnell
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: Patients with end-stage renal disease due to sickle cell disease (SCD-ESRD) have high mortality, which might be reduced by kidney transplantation (KT). However, whether…
2020 American Transplant Congress
Frequency and Main Diagnoses of Hospitalizations in Patients after Kidney Transplantation
W. Duettmann-Rehnolt, P. Glander, P. Bach, F. Halleck, V. Graf, L. Lehner, M. Duerr, M. Mayrdorfer, K. Budde, M. Naik
Nephrology, Charité-Universitätsmedizin Berlin, Berlin, Germany
*Purpose: Kidney transplant recipients (KTR) suffer many complications and are hospitalized frequently. Specific reasons for hospital admission with detailed information are scarce.*Methods: We retrieved data…
2020 American Transplant Congress
The Heart of the Matter: The Impact of the 2018 Heart Allocation Policy at a Single Organ Procurement Organization
A. J. Boyer, J. B. Nave, C. A. Hostetler, C. C. Muse, R. A. Squires, J. P. Orlowski
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK
*Purpose: In 2018, allocation policy changed with the goal of lowering waitlist mortality by increasing access to donor hearts. We sought to describe the impact…
2020 American Transplant Congress
Estimating the Potential Pool of Uncontrolled DCD Donors in the United States
B. J. Boyarsky, K. R. Jackson, A. B. Kernodle, J. V. Sakran, J. M. Garonzik Wang, S. E. Ottmann, D. L. Segev
Johns Hopkins, Baltimore, MD
*Purpose: In contrast to donation after brain death (DBD), donation after circulatory death (DCD) involves recovery of organs from people with devastating neurologic injury who…
2020 American Transplant Congress
What’s Lung Got to Do with It?: The Impact of the 2017 Lung Allocation Policy at a Single Organ Procurement Organization
A. J. Boyer, J. B. Nave, C. A. Hostetler, C. C. Muse, R. A. Squires, J. P. Orlowski
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK
*Purpose: To describe the impact of the lung allocation change on a single organ procurement organization (OPO). The allocation change took place on 11/24/2017 and…